查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
遺傳基因檢驗市場(第12版):各用途，各技術，各產品，用戶市場分析 - 執行指南附著(2025年～2029年)
市場調查報告書
商品編碼
1720943

遺傳基因檢驗市場(第12版):各用途，各技術，各產品，用戶市場分析 - 執行指南附著(2025年～2029年)

Genetic Testing Markets 12th Edition. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users. With Executive and Consultant Guides 2025 to 2029
出版日期: | 出版商: Howe Sound Research | 英文 565 Pages | 商品交期: 最快1-2個工作天內

價格

成長潛力無限嗎？基因檢測已經跨越國界，如今在各個領域蓬勃發展。其中蘊含著哪些機會與陷阱？

基因在健康和疾病中的作用才剛開始被人們所理解。這些新知識加上更低的價格，正在推動基因檢測產業創紀錄的成長。新藥可能只對擁有特定基因的人有效，這也推動了基因檢測產業的發展。傳統的基因檢測市場正在經歷檢測量的增加和檢測種類的多樣化，這為該行業帶來了新的機會和挑戰。本報告對14個國家和5個地區進行了詳細的細分。

透過揭秘預測診斷、藥物基因組學檢測和D2C等技術，幫助您了解這些技術。我們為您提供問題和機會，以及未來5年的成長預測和最終市場預測。

使用最新數據，自信地做出投資決策和評估。

本報告提供全球遺傳基因檢驗市場相關調查，市場概要，以及各用途，各技術，各產品，按用戶趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 市場指南

第2章 簡介和市場定義

  • 本報告書的遺傳基因檢驗定義
  • 基因學革命
  • 市場定義
  • 調查手法
  • 觀點:醫療保健和IVD產業
  • 染色體，遺傳基因，表觀遺傳學

第3章 市場概要

  • 市場進入組織
    • 學術研究機關
    • 診斷測試開發商
    • 測量設備供應商
    • 藥品·試劑廠商
    • 病理供應商
    • 獨立型臨床檢驗室
    • 公共的國立/地區研究所
    • 醫院檢驗室
    • 臨床檢驗室
    • 審核機關
    • 認證機關
  • 遺傳基因檢驗- 種類，案例，考察
  • 產業結構

第4章 市場趨勢

  • 成長促進因素
  • 阻礙成長的要素
  • 測量，自動化，診斷趨勢

第5章 遺傳基因檢驗的最近的趨勢

第6章 主要企業的簡介

  • 10x Genomics, Inc.
  • 23andME Inc.
  • Abbott Laboratories
  • Adaptive Biotechnologies
  • Admera Health, LLC
  • Agilent
  • Akonni Biosystems
  • Amoy Diagnostics Co., Ltd.
  • Ancestry.com LLC
  • Anchor Dx
  • Arrayit Corporation
  • ARUP Laboratories
  • Aus Diagnostics
  • BaseClear
  • Baylor Miraca Genetics Laboratories
  • Beckman Coulter Diagnostics(Danaher)
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd
  • Bioarray Genetics
  • BioBam
  • Biocept, Inc.
  • Biodesix Inc.
  • BioFluidica
  • BioGenex
  • BioGX
  • Biolidics Ltd
  • bioMerieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • Burning Rock
  • C2i Genomics
  • Cantata Bio
  • CareDx
  • Caris Molecular Diagnostics
  • Celemics
  • CellMax Life
  • Centogene
  • Cepheid(Danaher)
  • Circulogene
  • Clearbridge Biomedics
  • Clinical Genomics
  • Color Genomics
  • Complete Genomics(MGI Tech)
  • CosmosID
  • Dante Labs
  • Datar Cancer Genetics Limited
  • Diasorin S.p.A.
  • DNAe
  • Easy DNA
  • Element Biosciences
  • Epic Sciences
  • Epigenomics AG
  • Eurofins Scientific
  • Excellerate Bioscience
  • Fabric Genomics
  • Freenome
  • FUJIFILM Wako Diagnostics
  • Fujirebio
  • Fulgent Genetics
  • Gene by Gene, Ltd.
  • Genedrive
  • GeneDx Holdings
  • GeneFirst Ltd.
  • Genetic Technologies Ltd.
  • Genetron Holdings
  • Genomics England
  • Genomics Personalized Health(GPH)
  • GenomOncology
  • Genzyme Corporation
  • Grifols
  • Guardant Health
  • Guardiome
  • Helix
  • Hologic
  • HTG Molecular Diagnostics
  • Human Longevity, Inc.
  • iCellate
  • Illumina
  • Incell Dx
  • Inivata
  • Invitae Corporation
  • Invivoscribe
  • Karius
  • Letsgetchecked
  • Lunglife AI Inc
  • Macrogen
  • MDNA Life SCIENCES, Inc.
  • MDx Health
  • Medgenome
  • Menarini Silicon Biosystems
  • Meridian Bioscience
  • Mesa Laboratories, Inc.
  • Metabiomics Corp
  • miR Scientific
  • NantHealth, Inc.
  • Natera
  • Nebula Genomics
  • NeoGenomics
  • New England Biolabs, Inc.
  • NGeneBio
  • Norgen Biotek Corp.
  • Novogene
  • Omega Bioservices
  • Oncocyte
  • OncoDNA
  • OpGen
  • Origene Technologies
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Panagene
  • PathoQuest S.A.
  • Personalis
  • PGDx(Labcorp)
  • Precipio
  • PrecisionMed
  • Predictive Oncology
  • Promega
  • Qiagen
  • QuantuMDx
  • Revvity
  • Roche Diagnostics
  • Roswell Biotechnologies
  • Seegene
  • Sequencing.com
  • Siemens Healthineers
  • simfo GmbH
  • Singlera Genomics Inc.
  • Singular Genomics
  • SkylineDx
  • Standard BioTools
  • Sysmex
  • Sysmex Inostics
  • Tempus Labs, Inc.
  • Thermo Fisher Scientific
  • Ultima Genomics
  • Ultima Genomics
  • Variantyx
  • Vela Diagnostics
  • VolitionRX
  • Zymo Research Corp

第7章 全球市場規模

  • 各國全球市場
  • 各用途全球市場
  • 各技術全球市場
  • 各產品全球市場
  • 用戶全球市場

第8章 各用途市場

  • 新生兒檢驗
  • NIPT
  • 預測檢驗
  • 腫瘤學檢驗
  • DTC檢驗
  • 其他

第9章 各技術市場

  • PCR檢驗
  • NGS
  • 細胞遺傳學的檢驗
  • 其他

第10章 各產品市場

  • 設備
  • 試劑·套件
  • 軟體
  • 服務

第11章 用戶市場

  • 學術
  • 臨床
  • 醫藥品
  • 產業以及其他

第12章 遺傳基因檢驗的未來

第13章 附錄

OVERVIEW:

Unlimited growth potential? Genetic Testing has crossed the chasm and is now growing in every area. What are the opportunities? What are the pitfalls?

The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth. New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry. The traditional genetic testing market is growing in volume and growing in the breadth of tests creating new life, and new problems for the industry. The report includes detailed breakouts for 14 countries and 5 regions.

Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1. Market Guides

  • 1.1. Genetic Testing - Strategic Situation Analysis
  • 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
  • 1.3. Guide for Management Consultants and Investment Advisors
  • 1.4. Impact of Artificial Intelligence

2. Introduction and Market Definition

  • 2.1. Genetic Testing Definition in This Report
  • 2.2. The Genomics Revolution
  • 2.3. Market Definition
    • 2.3.1. Revenue Market Size.
    • 2.3.2. Newborn Screening
    • 2.3.3. Non Invasise Pregnancy Testing
    • 2.3.4. Predictive
    • 2.3.5. Oncology
    • 2.3.6. Direct to Consumer
    • 2.3.7. Other Application
    • 2.3.8. PCR
    • 2.3.9. NGS
    • 2.3.10. Cytogenetic
    • 2.3.11. Other Technology
  • 2.4. Methodology
    • 2.4.1. Methodology
    • 2.4.2. Sources
    • 2.4.3. Authors
  • 2.5. Perspective: Healthcare and the IVD Industry
    • 2.5.1. Global Healthcare Spending
    • 2.5.2. Spending on Diagnostics
    • 2.5.3. Important Role of Insurance for Diagnostics
  • 2.6. Chromosomes, Genes and Epigenetics
    • 2.6.1. Chromosomes
    • 2.6.2. Genes
    • 2.6.3. Epigenetics

3. Market Overview

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Instrumentation Supplier
    • 3.1.4. Chemical/Reagent Supplier
    • 3.1.5. Pathology Supplier
    • 3.1.6. Independent Clinical Laboratory
    • 3.1.7. Public National/regional Laboratory
    • 3.1.8. Hospital Laboratory
    • 3.1.9. Physicians Office Lab (POLS)
    • 3.1.10. Audit Body
    • 3.1.11. Certification Body
  • 3.2. Genetic Tests -Types, Examples and Discussion
    • 3.2.1. Preimplantation Genetic Diagnosis- An Emerging Market
    • 3.2.2. Prenatal Diagnosis - New Technologies Create Opportunity
    • 3.2.3. Newborn Screening
    • 3.2.4. Diagnostic Testing
    • 3.2.5. Carrier Testing
    • 3.2.6. Predictive and Presymptomatic Testing
    • 3.2.7. Pharmacogenomics
    • 3.2.8. Forensic Testing
    • 3.2.9. Parental Testing
    • 3.2.10. Ancestral Testing
  • 3.3. Industry Structure
    • 3.3.1. Hospital's Testing Share
    • 3.3.2. Economies of Scale
    • 3.3.3. Hospital vs. Central Lab
    • 3.3.4. Physician Office Lab's
    • 3.3.5. Physician's and POCT

4. Market Trends

  • 4.1. Factors Driving Growth
    • 4.1.1. Genetic Discoveries Impact.
    • 4.1.2. The Aging Effect
    • 4.1.3. Pharmacogenomics
    • 4.1.4. Oncology and Liquid Biopsy Factors
    • 4.1.5. Fertility Practice
    • 4.1.6. Direct to Consumer
  • 4.2. Factors Limiting Growth
    • 4.2.1. The Competition Effect
    • 4.2.2. The Cost Situation
    • 4.2.3. Testing usage analysis
    • 4.2.4. Wellness Effects
  • 4.3. Instrumentation, Automation and Diagnostic Trends
    • 4.3.1. Traditional Automation and Centralization
    • 4.3.2. The New Automation, Decentralization and Point of Care
    • 4.3.3. Instruments Key to Market Share
    • 4.3.4. Bioinformatics Plays a Role
    • 4.3.5. PCR Takes Command
    • 4.3.6. Next Generation Sequencing Fuels a Revolution
    • 4.3.7. NGS Impact on Pricing
    • 4.3.8. Whole Genome Sequencing, A Brave New World
    • 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
    • 4.3.10. Shifting Role of Diagnostics

5. Genetic Testing Recent Developments

  • 5.1. Recent Developments
    • 5.1.1. Importance of This Section
    • 5.1.2. How to Use This Section
  • 5.2. 23andMe Launches New Genetic Report
  • 5.3. Natera Revenues Soar on Product Gains
  • 5.4. GeneDx Launches Exome Testing for Epilepsy
  • 5.5. Owkin, AstraZeneca Partner to Develop AI Breast Cancer Prescreening Tool
  • 5.6. Myriad Genetics Reports Revenue Spike
  • 5.7. GeneDx Revenues Grow 45 Percent
  • 5.8. Revvity Launches NGS Panel for Newborn Screening
  • 5.9. LetsGetChecked: MyGeneticScreen
  • 5.10. Sysmex, Hitachi to Develop Low-Cost Sequencers
  • 5.11. Fore Genomics Offering WGS Newborn Screening to Parents
  • 5.12. Clinical Validation of Long-Read WGS Assay
  • 5.13. Resolution Bio Acquisition - Exact Sciences Aims at Liquid Biopsy Market
  • 5.14. Novitas Rescinds Coverage for Multiple Genetic Tests
  • 5.15. PerkinElmer (now Revvity) Becomes Dx Life Science Firm
  • 5.16. New POC Genotyping Tests Based on Electromagnetic Detection
  • 5.17. GenoMe Dx Launching dPCR Cancer Test
  • 5.18. mDetect To Trial Breast Cancer Liquid Biopsy
  • 5.19. Genomics England, Aims to Sequence 100K Newborns
  • 5.20. Juno Diagnostics NIPT With At-Home Sample Collection
  • 5.21. Cardio Diagnostics Launches Genetic Cario Risk Test
  • 5.22. Universal Genetic Testing in Breast Cancer Further Supported
  • 5.23. Aniling Gets CE-IVD Marks for Cancer Sequencing Tests
  • 5.24. MyOme Lands Investment for WGS
  • 5.25. Type 2 Diabetes GWAS Enables Risk Prediction
  • 5.26. LetsGetChecked to Acquire Veritas Genetics
  • 5.27. Guardant Health Plans New Comprehensive Assay
  • 5.28. Tesis Labs Raises $20M
  • 5.29. Sema4: Sema4 Elements
  • 5.30. Clarified Precision Medicine Acquires Interpares Biomedicine
  • 5.31. Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA
  • 5.32. Illumina, Belgium Genetic Centers Partner on WGS-Based Dx
  • 5.33. NIH, Genomics England Launch Sequencing Studies Using Nanopore Technology
  • 5.34. Progenity Revenues Fall on COVID-19 Effect
  • 5.35. Natera Launches Tumor Genomic Profiling Assay
  • 5.36. 23andMe To Go Public
  • 5.37. Guardant Health to Offer Tumor Tissue Sequencing
  • 5.38. Ancestry Quits Health Offering
  • 5.39. DTC Firm MyDNA Merges With Gene by Gene

6. Profiles of Key Companies

  • 6.1. 10x Genomics, Inc.
  • 6.2. 23andME Inc.
  • 6.3. Abbott Laboratories
  • 6.4. Adaptive Biotechnologies
  • 6.5. Admera Health, LLC
  • 6.6. Agilent
  • 6.7. Akonni Biosystems
  • 6.8. Amoy Diagnostics Co., Ltd.
  • 6.9. Ancestry.com LLC
  • 6.10. Anchor Dx
  • 6.11. Arrayit Corporation
  • 6.12. ARUP Laboratories
  • 6.13. Aus Diagnostics
  • 6.14. BaseClear
  • 6.15. Baylor Miraca Genetics Laboratories
  • 6.16. Beckman Coulter Diagnostics (Danaher)
  • 6.17. Becton, Dickinson and Company
  • 6.18. BGI Genomics Co. Ltd
  • 6.19. Bioarray Genetics
  • 6.20. BioBam
  • 6.21. Biocept, Inc.
  • 6.22. Biodesix Inc.
  • 6.23. BioFluidica
  • 6.24. BioGenex
  • 6.25. BioGX
  • 6.26. Biolidics Ltd
  • 6.27. bioMerieux Diagnostics
  • 6.28. Bioneer Corporation
  • 6.29. Bio-Rad Laboratories, Inc
  • 6.30. Bio-Techne
  • 6.31. Burning Rock
  • 6.32. C2i Genomics
  • 6.33. Cantata Bio
  • 6.34. CareDx
  • 6.35. Caris Molecular Diagnostics
  • 6.36. Celemics
  • 6.37. CellMax Life
  • 6.38. Centogene
  • 6.39. Cepheid (Danaher)
  • 6.40. Circulogene
  • 6.41. Clearbridge Biomedics
  • 6.42. Clinical Genomics
  • 6.43. Color Genomics
  • 6.44. Complete Genomics (MGI Tech)
  • 6.45. CosmosID
  • 6.46. Dante Labs
  • 6.47. Datar Cancer Genetics Limited
  • 6.48. Diasorin S.p.A.
  • 6.49. DNAe
  • 6.50. Easy DNA
  • 6.51. Element Biosciences
  • 6.52. Epic Sciences
  • 6.53. Epigenomics AG
  • 6.54. Eurofins Scientific
  • 6.55. Excellerate Bioscience
  • 6.56. Fabric Genomics
  • 6.57. Freenome
  • 6.58. FUJIFILM Wako Diagnostics
  • 6.59. Fujirebio
  • 6.60. Fulgent Genetics
  • 6.61. Gene by Gene, Ltd.
  • 6.62. Genedrive
  • 6.63. GeneDx Holdings
  • 6.64. GeneFirst Ltd.
  • 6.65. Genetic Technologies Ltd.
  • 6.66. Genetron Holdings
  • 6.67. Genomics England
  • 6.68. Genomics Personalized Health (GPH)
  • 6.69. GenomOncology
  • 6.70. Genzyme Corporation
  • 6.71. Grifols
  • 6.72. Guardant Health
  • 6.73. Guardiome
  • 6.74. Helix
  • 6.75. Hologic
  • 6.76. HTG Molecular Diagnostics
  • 6.77. Human Longevity, Inc.
  • 6.78. iCellate
  • 6.79. Illumina
  • 6.80. Incell Dx
  • 6.81. Inivata
  • 6.82. Invitae Corporation
  • 6.83. Invivoscribe
  • 6.84. Karius
  • 6.85. Letsgetchecked
  • 6.86. Lunglife AI Inc
  • 6.87. Macrogen
  • 6.88. MDNA Life SCIENCES, Inc.
  • 6.89. MDx Health
  • 6.90. Medgenome
  • 6.91. Menarini Silicon Biosystems
  • 6.92. Meridian Bioscience
  • 6.93. Mesa Laboratories, Inc.
  • 6.94. Metabiomics Corp
  • 6.95. miR Scientific
  • 6.96. NantHealth, Inc.
  • 6.97. Natera
  • 6.98. Nebula Genomics
  • 6.99. NeoGenomics
  • 6.100. New England Biolabs, Inc.
  • 6.101. NGeneBio
  • 6.102. Norgen Biotek Corp.
  • 6.103. Novogene
  • 6.104. Omega Bioservices
  • 6.105. Oncocyte
  • 6.106. OncoDNA
  • 6.107. OpGen
  • 6.108. Origene Technologies
  • 6.109. Oxford Nanopore Technologies
  • 6.110. Pacific Biosciences
  • 6.111. Panagene
  • 6.112. PathoQuest S.A.
  • 6.113. Personalis
  • 6.114. PGDx (Labcorp)
  • 6.115. Precipio
  • 6.116. PrecisionMed
  • 6.117. Predictive Oncology
  • 6.118. Promega
  • 6.119. Qiagen
  • 6.120. QuantuMDx
  • 6.121. Revvity
  • 6.122. Roche Diagnostics
  • 6.123. Roswell Biotechnologies
  • 6.124. Seegene
  • 6.125. Sequencing.com
  • 6.126. Siemens Healthineers
  • 6.127. simfo GmbH
  • 6.128. Singlera Genomics Inc.
  • 6.129. Singular Genomics
  • 6.130. SkylineDx
  • 6.131. Standard BioTools
  • 6.132. Sysmex
  • 6.133. Sysmex Inostics
  • 6.134. Tempus Labs, Inc.
  • 6.135. Thermo Fisher Scientific
  • 6.136. Ultima Genomics
  • 6.137. Ultima Genomics
  • 6.138. Variantyx
  • 6.139. Vela Diagnostics
  • 6.140. VolitionRX
  • 6.141. Zymo Research Corp

7. Global Market Size

  • 7.1. Global Market by Country
    • 7.1.1. Table - Global Market by Country
    • 7.1.2. Chart - Country Market Shares
  • 7.2. Global Market by Application
    • 7.2.1. Table - Global Market by Application
    • 7.2.2. Chart - Application Share by Year
    • 7.2.3. Chart - Application Segment Growth Rates
    • 7.2.4. Chart - Application Segment Share Shifts
    • 7.2.5. Chart - Application Segment Share Base Year
    • 7.2.6. Chart - Application Segment Share Final Year
  • 7.3. Global Market by Technology
    • 7.3.1. Table - Global Market by Technology
    • 7.3.2. Chart - Technology Share by Year
    • 7.3.3. Chart - Technology Segment Growth Rates
    • 7.3.4. Chart - Technology Segment Share Shifts
    • 7.3.5. Chart - Technology Segment Share Base Year
    • 7.3.6. Chart - Technology Segment Share Final Year
  • 7.4. Global Market by Product
    • 7.4.1. Table - Global Market by Product
    • 7.4.2. Chart - Product Share by Year
    • 7.4.3. Chart - Product Segment Growth Rates
    • 7.4.4. Chart - Product Segment Share Shifts
    • 7.4.5. Chart - Product Segment Share Base Year
    • 7.4.6. Chart - Product Segment Share Final Year
  • 7.5. Global Market by User
    • 7.5.1. Table - Global Market by User
    • 7.5.2. Chart - User Share by Year
    • 7.5.3. Chart - User Segment Growth Rates
    • 7.5.4. Chart - User Segment Share Shifts
    • 7.5.5. Chart - User Segment Share Base Year
    • 7.5.6. Chart - User Segment Share Final Year

8. Market Sizes by Application

  • 8.1. Newborn Testing Market
    • 8.1.1. Table Newborn - by Country
    • 8.1.2. Chart - Newborn Growth
  • 8.2. NIPT Market
    • 8.2.1. Table NIPT - by Country
    • 8.2.2. Chart - NIPT Growth
  • 8.3. Predictive Testing Market
    • 8.3.1. Table Predictive - by Country
    • 8.3.2. Chart - Predictive Growth
  • 8.4. Oncology Testing Market
    • 8.4.1. Table Oncology - by Country
    • 8.4.2. Chart - Oncology Growth
  • 8.5. DTC Testing Market
    • 8.5.1. Table DTC - by Country
    • 8.5.2. Chart - DTC Growth
  • 8.6. Other Testing Market
    • 8.6.1. Table Other - by Country
    • 8.6.2. Chart - Other Growth

9. Global Genetic Testing Market by Technology

  • 9.1. PCR Testing Market
    • 9.1.1. Table PCR - by Country
    • 9.1.2. Chart - PCR Growth
  • 9.2. NGS Market
    • 9.2.1. Table NGS - by Country
    • 9.2.2. Chart - NGS Growth
  • 9.3. Cytogenetic Testing Market
    • 9.3.1. Table Cytogenetic - by Country
    • 9.3.2. Cytogenetic - Predictive Growth
  • 9.4. Other Testing Market
    • 9.4.1. Table Other - by Country
    • 9.4.2. Chart - Other Growth

10. Global Genetic Testing Market by Product

  • 10.1. Instruments Market
    • 10.1.1. Table Instruments - by Country
    • 10.1.2. Chart - Instrument Growth
  • 10.2. Reagents and Kits Market
    • 10.2.1. Table Reagents and Kits - by Country
    • 10.2.2. Chart - Reagents and Kits Growth
  • 10.3. Software Market
    • 10.3.1. Table Software - by Country
    • 10.3.2. Software Growth
  • 10.4. Services Market
    • 10.4.1. Table Services - by Country
    • 10.4.2. Chart - Services Growth

11. Global Genetic Testing Market by User

  • 11.1. Academic Market
    • 11.1.1. Table Academic - by Country
    • 11.1.2. Chart - Academic Growth
  • 11.2. Clinical Market
    • 11.2.1. Table Clinical - by Country
    • 11.2.2. Chart - Clinical Growth
  • 11.3. Pharmaceutical Market
    • 11.3.1. Table Pharmaceutical - by Country
    • 11.3.2. Pharmaceutical - Predictive Growth
  • 11.4. Industrial and Other Market
    • 11.4.1. Table Industrial and Other - by Country
    • 11.4.2. Chart - Industrial and Other Growth

12. The Future of Genetic Testing

13. Appendices

  • 13.1. Growth of Approved IVD Test Menu
  • 13.2. Growth of Approved Average IVD Test Fee
  • 13.3. The Most Used IVD Assays
  • 13.4. The Highest Grossing Assays
  • 13.5. Laboratory Fees Schedule

Table of Tables

  • Table 1: Most Common Traditional Genetic Disorders
  • Table 2: The Base Pairs
  • Table 3: Market Players by Type
  • Table 4: The Different Types of Genetic Tests
  • Table 5: Five Factors Driving Growth
  • Table 6: Four Factors Limiting Growth
  • Table 7: Seven Key Diagnostic Laboratory Technology Trends
  • Table 8: Global Market by Country
  • Table 9: Global Market by Application
  • Table 10: Global Market by Technology
  • Table 11: Global Market by Product
  • Table 12: Global Market by User
  • Table 13: Newborn Segment by Country
  • Table 14: NIPT Segment by Country
  • Table 15: Predictive Segment by Country
  • Table 16: Oncology Segment by Country
  • Table 17: DTC Segment by Country
  • Table 18: Other Segment by Country
  • Table 19: PCR Segment by Country
  • Table 20: NGS Segment by Country
  • Table 21: Cytogenetic Segment by Country
  • Table 22: Other Segment by Country
  • Table 23: Instruments Segment by Country
  • Table 24: Reagents and Kits Segment by Country
  • Table 25: Software Segment by Country
  • Table 26: Services Segment by Country
  • Table 27: Academic Segment by Country
  • Table 28: Clinical Segment by Country
  • Table 29: Pharmaceutical Segment by Country
  • Table 30: Industrial and Other Segment by Country
  • Table 31: The Most Common Assays
  • Table 32: Largest Revenue Assays
  • Table 33: Clinical Lab Fee Schedule

Table of Figures

  • Figure 1: Global Health Care Spending
  • Figure 2: The Lab Test Pie
  • Figure 3: DNA Strands and Chromosomes
  • Figure 4: Karyogram of Human Chromosomes
  • Figure 5: Size of Various Genomes
  • Figure 6: The Road to Diagnostics
  • Figure 7: The Changing Age of the World Population
  • Figure 8: Health Care Consumption by Age
  • Figure 9: Cancer Incidence - Age at Diagnosis
  • Figure 10: Centralized vs. Decentralized Laboratory Service
  • Figure 11: A Highly Multiplexed Syndromic Testing Unit
  • Figure 12: The Real Cost to Sequence the Human Genome
  • Figure 13: The Codevelopment Process
  • Figure 14: Comparing MDx Diagnostic and Traditional Testing
  • Figure 15: Country Market Shares
  • Figure 16: Application Share by Year
  • Figure 17: Application Segment Growth Rates
  • Figure 18: Segment Share Shifts
  • Figure 19: Application Segment Share Base Year
  • Figure 20: Application Segment Share Final Year
  • Figure 21: Technology Share by Year
  • Figure 22: Technology Segment Growth Rates
  • Figure 23: Technology Segment Share Shifts
  • Figure 24: Technology Segment Share Base Year
  • Figure 25: Technology Segment Share Final Year
  • Figure 26: Product Share by Year
  • Figure 27: Product Segment Growth Rates
  • Figure 28: Product Segment Share Shifts
  • Figure 29: Product Segment Share Base Year
  • Figure 30: Product Segment Share Final Year
  • Figure 31: User Share by Year
  • Figure 32: User Segment Growth Rates
  • Figure 33: User Segment Share Shifts
  • Figure 34: User Segment Share Base Year
  • Figure 35: User Segment Share Final Year
  • Figure 36: Newborn vs. Total Market Growth
  • Figure 37: NIPT vs. Total Market Growth
  • Figure 38: Predictive vs. Total Market Growth
  • Figure 39: Oncology vs. Total Market Growth
  • Figure 40: DTC vs. Total Market Growth
  • Figure 41: Other vs. Total Market Growth
  • Figure 42: PCR vs. Total Market Growth
  • Figure 43: NGS vs. Total Market Growth
  • Figure 44: Cytogenetic vs. Total Market Growth
  • Figure 45: Other vs. Total Market Growth
  • Figure 46: Instrument vs. Total Market Growth
  • Figure 47: Reagents and Kits vs. Total Market Growth
  • Figure 48: Software vs. Total Market Growth
  • Figure 49: Services vs. Total Market Growth
  • Figure 50: Academic vs. Total Market Growth
  • Figure 51: Clinical vs. Total Market Growth
  • Figure 52: Pharmaceutical vs. Total Market Growth
  • Figure 53: Industrial and Other vs. Total Market Growth
  • Figure 54: IVD Test Menu Growth
  • Figure 55: IVD Test Average Fees - A Ten Year View